A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

<div>Between-treatment differences in mean intraocular pressure (IOP) change from baseline in patients with baseline IOP ≥ 25 versus &lt;25 mmHg. Difference = TFC − DFC. Statistical significance was determined using the 2-sample <i>t</i>-test. Number of TFC and DFC patients, respectively, in each subpopulation: mITT, &lt; 25 mmHg: 57, 51; mITT, ≥ 25 mmHg: 36, 46. DFC: dual fixed-combination; mITT,: modified intent-to-treat; TFC: triple fixed-combination.</div>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure 

Figure 2 | A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure 